Daniel C. Martin
2019
In 2019, Daniel C. Martin earned a total compensation of $2.1M as Chief Commercial Officer at Deciphera Pharmaceuticals, a 34% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $253,344 |
|---|---|
| Option Awards | $907,426 |
| Salary | $420,000 |
| Other | $505,549 |
| Total | $2,086,319 |
Martin received $907.4K in option awards, accounting for 43% of the total pay in 2019.
Martin also received $253.3K in non-equity incentive plan, $420K in salary and $505.5K in other compensation.
Rankings
In 2019, Daniel C. Martin's compensation ranked 5,718th out of 13,971 executives tracked by ExecPay. In other words, Martin earned more than 59.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,718 out of 13,971 | 59th |
Division Manufacturing | 2,141 out of 5,695 | 62nd |
Major group Chemicals And Allied Products | 771 out of 2,194 | 65th |
Industry group Drugs | 648 out of 1,880 | 66th |
Industry Pharmaceutical Preparations | 475 out of 1,392 | 66th |
Source: SEC filing on April 26, 2022.
Martin's colleagues
We found four more compensation records of executives who worked with Daniel C. Martin at Deciphera Pharmaceuticals in 2019.